lundi 20 avril 2015

94% des biotech de l'indice Nasdaq Biotechnology ont une valorisation > 300M$


Valeur CB CA PER
ACADIA 3,81B 150,00K
Acceleron P 1,10B 14,64M
AcelRx 207,21M 5,23M
Achillion 1,21B
Acorda 1,47B 659,65M 82,71
Aegerion 719,76M 158,36M
Aerie Pharmace 821,20M
Affymetrix 933,19M 349,02M
Agios Pharm 4,01B 65,36M
Akebia Ther 169,28M
Akorn 6,06B 601,93M 164,05
Albany Molecular 615,29M 276,57M
Alder Bioph 1,02B 54,70M 371,37
Alexion 36,20B 2,23B 55,66
Alimera 222,21M 10,50M
Alkermes 9,32B 618,78M
Alnylam 9,83B 50,56M
AMAG 1,75B 124,38M 15,33
Amgen 123,98B 20,06B 24,42
Amicus 1,15B 1,22M
Amphastar P 674,80M 210,46M

Anacor
2,96B 20,69M
ANI Pharmaceuticals 769,15M 66,88M 27,22
Aratana Thr 565,20M 770,00K
Arena 1,12B 36,96M
ARIAD 1,69B 105,40M
Array BioPharma 1,02B 46,77M
Auspex Pharma 3,20B
Avalanche Biotec 1,02B 570,00K
BIO-TECHNE Corp 3,75B 408,51M 32,51
BioCryst 708,64M 13,62M
Biogen Inc 98,41B 9,70B 33,88

BioMarin
19,24B 751,04M
Bluebird 4,32B 25,42M
Cara Therapeutic 271,62M 3,17M
Celgene 90,84B 7,67B 47,35
Celladon Corp 393,76M
Celldex 2,62B 4,01M
Cempra 1,61B 15,22M
Cerus 383,57M 36,50M
ChemoCentryx 337,60M
Chimerix 1,58B 4,05M
Clovis 2,93B 13,62M
Compugen Ltd 360,50M 12,36M
Concert Pha 323,80M 8,58M
Depomed 1,55B 466,91M 14,04
Dyax 4,06B 81,73M
Enanta 675,11M 124,35M 8,54
Endo 16,60B 2,88B
Endocyte 258,69M 70,35M 61,28
Epizyme 735,58M 41,41M
Exelixis 609,32M 25,11M
Five Prm Th 616,87M 19,23M
Flamel 613,57M 32,04M
Foundation 1,69B 61,09M
Genomic 977,41M 275,71M
Geron 626,65M 1,15M
Gilead 150,35B 36,42B 13,76
Grifols 4,65B
GW 2,19B 58,52M
Halozyme 1,94B 75,35M
Horizon Pharma 4,55B 296,96M
Hyperion 956,88M 133,07M
Illumina 27,53B 1,86B 80,47
ImmunoGen 871,41M 74,12M
Immunomedics 384,76M 4,41M
Impax Labs 3,59B 596,05M 61,33
Incyte 17,63B 601,29M
Infinity 726,96M 165,00M
Inovio 609,84M 10,46M
Insmed 1,39B
Insys 2,16B 222,13M 58,71
Intercept 6,57B 1,76M
Ironwood 2,13B 76,44M
ISIS 7,78B 214,16M
Jazz 11,35B 1,17B 283,57
Karyopharm Thera 1,21B 220,00K
Kite Pharma 2,77B
Kythera 1,26B
Lexicon 746,90M 22,86M
Ligand 1,69B 107,07M 150,55
Luminex 702,67M 226,98M 17,6
Macrogenics 986,28M 47,80M
MannKind 2,06B
Medivation 9,99B 710,49M 38,74
Merrimack 1,41B 102,76M
Momenta 965,87M 52,26M
Mylan 34,17B 7,72B 29,89
Myriad 2,51B 724,92M 24,47
Nektar 1,57B 200,70M
Neurocrine 3,59B
NewLink 1,53B 172,59M 23,81
Novavax 2,16B 30,65M
Omeros 915,20M 530,00K
Oncomed Pha 765,02M 39,56M
Ophthotech 1,73B 41,26M
Orexigen 932,91M 55,53M
Osiris 562,34M 93,26M
Pacific Biosciences 458,43M 60,59M
Pacira 3,07B 234,33M
PDL BioPharma 1,18B 581,22M 3,94
Pernix 320,53M 140,79M
Pharmacyclics 19,77B 729,73M 239,19
Portola 1,97B 9,63M
Pozen 251,52M 39,95M 13,11
Progenics 444,30M 44,38M 488,89
Prothena 1,10B 50,85M
Ptc Therape 2,38B 25,25M
Qiagen NV 6,03B 1,35B 51,99
QLT Inc 197,70M
Radius Heal 1,57B
Raptor Pharmaceutical 859,62M 110,08M
Receptos 5,28B 5,90M
Regeneron 45,92B 2,82B 145,64
Regulus 873,94M 7,67M
Relypsa Inc 1,45B
Repligen 1,05B 79,88M 130,56
Retrophin I 790,80M 28,20M
Revance The 534,53M 370,00K
Sage Therapeutic 1,68B
Sagent 818,04M 289,78M 20,92
Sangamo 1,00B 45,87M
Sarepta 546,96M 9,76M
SciClone 444,50M 134,79M 18,49
Seattle Genetics 4,51B 286,76M
Sequenom 504,91M 151,57M
Shire 47,96B 6,02B 14,63
Sinovac 279,52M 65,74M 77,25
Spectrum 399,22M 186,82M
Sucampo 902,33M 115,45M 70,24
Supernus 630,12M 160,80M 39,96
Synageva 3,83B 6,50M
Synergy 432,21M
Synta 393,85M
Tetraphase 1,43B 10,38M
The Medicines 1,91B 1,09B
Theravance 2,00B 8,43M
Theravance Biopharma Inc 609,11M 11,68M
Ultragenyx 2,24B
United Therapeutics 8,64B 1,29B 30,05
Vanda 412,25M 59,30M 32,42
Verastem 351,28M
Versartis Inc 556,15M
Vertex 30,28B 698,87M
VIVUS 251,39M 114,18M
XenoPort 448,14M 46,87M
XOMA 432,67M 18,87M
Zafgen Inc 952,33M
Zs Pharma I 1,01B

La plus basse valorisation boursière étant AKEBIA THER pour 169M$ Il est donc tout à fait logique que les biotechs françaises continuent de monter surtout si elles ont un pied aux USA.